Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 23069657)

1.

DNA damage-induced sustained p53 activation contributes to inflammation-associated hepatocarcinogenesis in rats.

Yan HX, Wu HP, Zhang HL, Ashton C, Tong C, Wu J, Qian QJ, Wang HY, Ying QL.

Oncogene. 2013 Sep 19;32(38):4565-71. doi: 10.1038/onc.2012.451. Epub 2012 Oct 15.

2.

Caught in the cross fire: p53 in inflammation.

Cooks T, Harris CC, Oren M.

Carcinogenesis. 2014 Aug;35(8):1680-90. doi: 10.1093/carcin/bgu134. Epub 2014 Jun 18. Review.

PMID:
24942866
3.

Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.

Zheng T, Yin D, Lu Z, Wang J, Li Y, Chen X, Liang Y, Song X, Qi S, Sun B, Xie C, Meng X, Pan S, Liu J, Jiang H, Liu L.

Mol Cancer. 2014 May 31;13:133. doi: 10.1186/1476-4598-13-133.

4.

The effect of adenovirus-conjugated NDRG2 on p53-mediated apoptosis of hepatocarcinoma cells through attenuation of nucleotide excision repair capacity.

Cao W, Zhang JL, Feng DY, Liu XW, Li Y, Wang LF, Yao LB, Zhang H, Zhang J.

Biomaterials. 2014 Jan;35(3):993-1003.

PMID:
24383128
5.

p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.

Fornari F, Milazzo M, Galassi M, Callegari E, Veronese A, Miyaaki H, Sabbioni S, Mantovani V, Marasco E, Chieco P, Negrini M, Bolondi L, Gramantieri L.

Mol Cancer Res. 2014 Feb;12(2):203-16. doi: 10.1158/1541-7786.MCR-13-0312-T. Epub 2013 Dec 9.

6.

APE1/Ref-1 enhances DNA binding activity of mutant p53 in a redox-dependent manner.

Cun Y, Dai N, Li M, Xiong C, Zhang Q, Sui J, Qian C, Wang D.

Oncol Rep. 2014 Feb;31(2):901-9. doi: 10.3892/or.2013.2892. Epub 2013 Dec 2.

PMID:
24297337
7.

c-ABL tyrosine kinase modulates p53-dependent p21 induction and ensuing cell fate decision in response to DNA damage.

Udden SM, Morita-Fujimura Y, Satake M, Ikawa S.

Cell Signal. 2014 Feb;26(2):444-52. doi: 10.1016/j.cellsig.2013.10.005. Epub 2013 Oct 28.

PMID:
24177958
8.

Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish.

Lu JW, Yang WY, Tsai SM, Lin YM, Chang PH, Chen JR, Wang HD, Wu JL, Jin SL, Yuh CH.

PLoS One. 2013 Oct 9;8(10):e76951. doi: 10.1371/journal.pone.0076951. eCollection 2013.

9.

Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice.

Ip BC, Hu KQ, Liu C, Smith DE, Obin MS, Ausman LM, Wang XD.

Cancer Prev Res (Phila). 2013 Dec;6(12):1304-16. doi: 10.1158/1940-6207.CAPR-13-0178. Epub 2013 Oct 1.

10.

Two-stage model of chemically induced hepatocellular carcinoma in mouse.

Luo M, Yang F, Huang SX, Kuang ZP, Luo XL, Li YD, Wu JN, Xie YA.

Oncol Res. 2013;20(11):517-28. doi: 10.3727/096504013X13747716581336.

PMID:
24063282
11.

Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway.

Yi G, He Z, Zhou X, Xian L, Yuan T, Jia X, Hong J, He L, Liu J.

Int J Oncol. 2013 Nov;43(5):1503-10. doi: 10.3892/ijo.2013.2077. Epub 2013 Aug 23.

PMID:
23982736
12.

Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E.

Tu K, Zheng X, Zhou Z, Li C, Zhang J, Gao J, Yao Y, Liu Q.

PLoS One. 2013 Jul 1;8(7):e68574. doi: 10.1371/journal.pone.0068574. Print 2013.

13.

p53 promotes inflammation-associated hepatocarcinogenesis by inducing HMGB1 release.

Yan HX, Wu HP, Zhang HL, Ashton C, Tong C, Wu H, Qian QJ, Wang HY, Ying QL.

J Hepatol. 2013 Oct;59(4):762-8. doi: 10.1016/j.jhep.2013.05.029. Epub 2013 May 25.

14.
15.

Down-regulation of wild-type p53-induced phosphatase 1 (Wip1) plays a critical role in regulating several p53-dependent functions in premature senescent tumor cells.

Crescenzi E, Raia Z, Pacifico F, Mellone S, Moscato F, Palumbo G, Leonardi A.

J Biol Chem. 2013 Jun 7;288(23):16212-24. doi: 10.1074/jbc.M112.435149. Epub 2013 Apr 23.

16.

Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress.

Yang C, Lu W, Lin T, You P, Ye M, Huang Y, Jiang X, Wang C, Wang F, Lee MH, Yeung SC, Johnson RL, Wei C, Tsai RY, Frazier ML, McKeehan WL, Luo Y.

BMC Gastroenterol. 2013 Apr 17;13:67. doi: 10.1186/1471-230X-13-67.

17.

Cyclin E facilitates dysplastic hepatocytes to bypass G1/S checkpoint in hepatocarcinogenesis.

Pok S, Wen V, Shackel N, Alsop A, Pyakurel P, Fahrer A, Farrell GC, Teoh NC.

J Gastroenterol Hepatol. 2013 Sep;28(9):1545-54. doi: 10.1111/jgh.12216.

PMID:
23574010
18.

Non-cell-autonomous tumor suppression by p53.

Lujambio A, Akkari L, Simon J, Grace D, Tschaharganeh DF, Bolden JE, Zhao Z, Thapar V, Joyce JA, Krizhanovsky V, Lowe SW.

Cell. 2013 Apr 11;153(2):449-60. doi: 10.1016/j.cell.2013.03.020. Epub 2013 Apr 4.

19.

Toll-like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice.

Wang Z, Yan J, Lin H, Hua F, Wang X, Liu H, Lv X, Yu J, Mi S, Wang J, Hu ZW.

Hepatology. 2013 May;57(5):1869-81. doi: 10.1002/hep.26234. Epub 2013 Apr 5.

PMID:
23299825
20.

Oxidative stress-induced 1, N6-ethenodeoxyadenosine adduct formation contributes to hepatocarcinogenesis.

Zhou L, Yang Y, Tian D, Wang Y.

Oncol Rep. 2013 Mar;29(3):875-84. doi: 10.3892/or.2013.2227. Epub 2013 Jan 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk